Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccineResearch in context

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccineResearch in context

Summary: Background: To date, only a few studies reported data regarding the development of mucosal immune response after the BNT162b2-booster vaccination. Methods: Samples of both serum and saliva of 50 healthcare workers were collected at the day of the booster dose (T3) and after two weeks (T4)....

Full description

Bibliographic Details
Main Authors: Lorenzo Azzi, Daniela Dalla Gasperina, Giovanni Veronesi, Mariam Shallak, Vittorio Maurino, Andreina Baj, Francesco Gianfagna, Pierpaolo Cavallo, Francesco Dentali, Lucia Tettamanti, Fabrizio Maggi, Lorenzo Stefano Maffioli, Angelo Tagliabue, Roberto Sergio Accolla, Greta Forlani
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:EBioMedicine
Subjects:
BNT162b2 mRNA vaccine
COVID-19
SARS-CoV-2
Saliva
IgA
Online Access:http://www.sciencedirect.com/science/article/pii/S235239642200617X

Internet

http://www.sciencedirect.com/science/article/pii/S235239642200617X

Similar Items